[Pharmacokinetics of a new beta-receptor blockader (terbuclomin) in kidney failure].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists
Pharmakokinetik eines neuen beta-Rezeptorenblockers (Terbuclomin) bei Nieren-insuffizienz